Key facts
- Notable investors include Oregon Angel Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for PharmaVision ( korea )
- ·The full record, as it builds
Funding rounds
No funding rounds for PharmaVision ( korea ) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PharmaVision ( korea )
Provider of pharmaceutical formulation development and regulatory approval services intended to support the healthcare sector. The company offers drug formulation, product development, and regulatory filing services, enabling pharmaceutical and biotechnology companies to bring their drug products through the development and approval process.
- Sector
- Healthcare
- HQ
- Suwon, South Korea
- Founded
- 2020
- Website
- pharmavision.co.kr/
- Ownership
- Privately Held (backing)
PharmaVision ( korea ) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PharmaVision ( korea ) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PharmaVision ( korea ) in its N-PORT filings yet. We sweep new filings monthly.